T. Rowe Price Investment Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-475,222	Closed	-$18.1M	–	568
2022 Q4	$18.1M	Buy	475,222 +135	+0%	+$5.13K	0.01%	470
2022 Q3	$11.9M	Buy	+475,087	New	+$11.9M	0.01%	490